Pages that link to "Q47173676"
Jump to navigation
Jump to search
The following pages link to Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues (Q47173676):
Displaying 50 items.
- Effect of PBPK model structure on interpretation of in vivo human aqueous dermal exposure trials (Q23909856) (← links)
- Physiologically based pharmacokinetic modeling for 1-bromopropane in F344 rats using gas uptake inhalation experiments (Q23910662) (← links)
- Advances in inhalation dosimetry models and methods for occupational risk assessment and exposure limit derivation (Q23912442) (← links)
- Improved method for in vitro assessment of dermal toxicity for volatile organic chemicals (Q23914399) (← links)
- Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans (Q23915079) (← links)
- N-acetyl-S-(n-propyl)-L-cysteine in urine from workers exposed to 1-bromopropane in foam cushion spray adhesives (Q23915816) (← links)
- Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats (Q23915892) (← links)
- Calcium dynamics in cardiac myocytes as a target of dichloromethane cardiotoxicity (Q23919048) (← links)
- Human physiologically based pharmacokinetic model for propofol (Q24798495) (← links)
- Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference (Q24803127) (← links)
- A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment (Q24815444) (← links)
- Partitioning of benzene in blood: influence of hemoglobin type in humans and animals (Q24815920) (← links)
- Physiologically based pharmacokinetic modeling of organophosphorus and carbamate pesticides (Q25892170) (← links)
- Toxicity testing in the 21st century: a vision and a strategy (Q27921848) (← links)
- Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses (Q28860859) (← links)
- Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario (Q30503509) (← links)
- Prediction of in vivo tissue distribution from in vitro data 1. Experiments with markers of aqueous spaces (Q30608992) (← links)
- Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. (Q30656324) (← links)
- Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling (Q30665744) (← links)
- Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment (Q30925847) (← links)
- Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation (Q30932188) (← links)
- Prediction of blood:air and fat:air partition coefficients of volatile organic compounds for the interpretation of data in breath gas analysis (Q31040276) (← links)
- Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling (Q31077784) (← links)
- Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene. (Q31874913) (← links)
- Extrapolation of in vitro enzyme induction data to humans in vivo (Q32174139) (← links)
- Physiologically based pharmacokinetic modeling of cyclohexane as a tool for integrating animal and human test data. (Q33517439) (← links)
- Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions (Q33649338) (← links)
- Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve (Q33714957) (← links)
- Vinyl chloride: still a cause for concern (Q33910749) (← links)
- The applicability of in vitro-derived data in hazard identification and characterisation of chemicals (Q33969320) (← links)
- Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. (Q34181630) (← links)
- An Assessment of the Interindividual Variability of Internal Dosimetry during Multi-Route Exposure to Drinking Water Contaminants (Q34374608) (← links)
- Parents worried about breast milk contamination. What is best for baby? (Q34386916) (← links)
- Alveolar breath sampling and analysis to assess trihalomethane exposures during competitive swimming training (Q34438372) (← links)
- Changes in breath trihalomethane levels resulting from household water-use activities (Q34547097) (← links)
- Methods of in vitro toxicology (Q34563173) (← links)
- PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure. (Q34636088) (← links)
- Breath measurements as volatile organic compound biomarkers (Q34637320) (← links)
- A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling (Q34640379) (← links)
- Trichloroethylene [correction of Trichloroethene] levels in human blood and exhaled breath from controlled inhalation exposure (Q34938740) (← links)
- Trichloroethene levels in human blood and exhaled breath from controlled inhalation exposure (Q34938876) (← links)
- Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters (Q35030787) (← links)
- Physiologically based pharmacokinetics and cancer risk assessment (Q35031129) (← links)
- Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats (Q35057289) (← links)
- Whole body pharmacokinetic models (Q35186644) (← links)
- The application of global sensitivity analysis in the development of a physiologically based pharmacokinetic model for m-xylene and ethanol co-exposure in humans (Q35796328) (← links)
- The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling (Q35802386) (← links)
- PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene (Q35842496) (← links)
- Solubility of haloether anesthetics in human and animal blood. (Q36052090) (← links)
- Review and analysis of inhalation dosimetry methods for application to children's risk assessment (Q36131290) (← links)